Notice: Passwords are now case-sensitive
Forgot your password? Register a new account

Connections

Groups

Community Requests

Observers See Significant Changes in Last Expected Revision to Formulary Rules

By Greg Jones (Deputy Editor)

Wednesday, September 13, 2017 | 1403 | 0 | 0 min read

Observers say the California Division of Workers’ Compensation made important — if not major — changes to its proposed formulary regulations for what is expected to be the last public comment period before agency formally adopts the rules. The division on Thursday opened a second 15-day comment period on regulations first proposed in March to implement the prescription drug formulary that lawmakers mandated with passage of Assembly Bill 1124 in 2015. At its core, the formulary is essentially a list of drugs that are designated as “exempt” from pro...

Purchase this story for only $9.16!Add to Cart


For access to all of our articles, check out our subscription options.

Comments

Robert Rassp, Esq. Sep 13, 2017 08:06 AM

Your article quotes someone who says "weaning plans have to follow medically accepted guidelines." This is a very misleading statement that flows through the workers' compensation industry. In fact there are no medically accepted guidelines in any treatment protocol either evidence based or otherwise weaning patients from opioid, benzodiazepine, or hypnotic dependency. Just ask any addiction specialist. This area of medicine is new and emerging and we are a long way from determining the most effective way to wean people from these drugs. Experience shows for chronic pain patients, it can take up to three years or longer to wean someone from any one of these drugs, if at all. In every case, a treatment plan has to be patient-centered and cannot be vanilla flavored with one uniform standard applying to all patients. Robert G. Rassp, Esq. Chairman of the Board of Directors, Friends Research Institute www.friendsresearch.org

0 0
Gary Nelson Sep 13, 2017 01:19 PM

Thank you Robert. I agree wholeheartedly.

0 0

Related Articles